Washington ¨C U.S. President Donald Trump signed an executive order on Saturday intended to speed up access to medical research and treatment based on psychedelic drugs.
The order instructs the U.S. Food and Drug Administration to expedite the review of drugs such as ibogaine, which U.S. military veteran groups ?have said can help treat post-traumatic stress disorder.
Health Secretary Robert F. Kennedy Jr. has championed the idea of using drugs ?such as ?ibogaine as an alternative treatment for mental health conditions such as depression.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.